intybin has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; He, L; Li, Q; Ling, W; Liu, X; Shi, G; Wang, D; Weng, H; Zheng, J | 1 |
| Du, Y; He, L; Li, Q; Liu, X; Wang, D; Weng, H; Zheng, J | 1 |
2 other study(ies) available for intybin and Inflammation
| Article | Year |
|---|---|
Lactucopicrin Inhibits Cytoplasmic Dynein-Mediated NF-κB Activation in Inflammated Macrophages and Alleviates Atherogenesis in Apolipoprotein E-Deficient Mice.
Topics: Animals; Atherosclerosis; Cytoplasm; Dyneins; Inflammation; Lactones; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; NF-kappa B; Plaque, Atherosclerotic; Protein Transport; Sesquiterpenes; Transcription Factor RelA | 2021 |
Natural lactucopicrin alleviates importin-α3-mediated NF-κB activation in inflammated endothelial cells and improves sepsis in mice.
Topics: alpha Karyopherins; Animals; Dose-Response Relationship, Drug; Endothelial Cells; HL-60 Cells; Humans; Inflammation; Lactones; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Sepsis; Sesquiterpenes | 2021 |